Recrom And Sterile Diluent For Recrom 50 mg Powder and Solvent for Solution for Injection/Infusion
PDF Leaflet Revision Date: 13 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of multiple myeloma and ovarian cancer.
Dosage (summary)
8-30 mg/mu00b2 every 2-6 weeks; high doses 100-200 mg/mu00b2 with autologous bone marrow rescue.
Special Populations
- Renal impairment
- Elderly
- Children
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Nalidixic acid
- Ciclosporin
- Live vaccines
Contraindications
- Previous allergic reaction to melphalan
- Pregnancy
- Lactation
- Live vaccines
Common side effects
- Nausea
- Vomiting
- Thrombocytopenia
- Neutropenia
- Alopecia
Counselling Points
- Avoid pregnancy during treatment
- Monitor for bleeding signs
- Report any allergic reactions
Serious warnings
- Myelosuppression
- Leukaemogenic risk
- Mutagenicity
Important Disclaimer
The Recrom And Sterile Diluent For Recrom 50 mg Powder and Solvent for Solution for Injection/Infusion professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
